Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.

Total Artificial Heart

artificial heart
In the Leviev Heart Center at Sheba Medical Center, a unique two-chamber artificial heart transplant was performed for the sixth time in the world.

The patient was 23-year-old Nof Sadeh, who suffered a severe heart failure that endangered his life. The two-chamber artificial heart transplant was successful and Nof quickly recovered from the operation after which he was discharged.

The new HeartMate 3- two-chamber artificial heart, manufactured by the American company St. Jude Medical, implanted in the patient’s chest, includes two tiny pumps attached to each of the two failing heart chambers, acting in their stead. Each pump is powered by a rechargeable battery pack that is replaced once a day.

Transplantation of the two-chamber heart allows the patient to be discharged to his home, to return to routine activity, and wait for the day when he will receive a heart donation for the transplant.

Total Artificial Heart
Prof. Jacob Lavee performs Total Artificial Heart

Most patients with terminal heart failure suffer from the failure of the left ventricle of the heart alone and therefore, if necessary, a single auxiliary device is implanted into the failing room. A small portion of the patients suffer from the failure of the two ventricles of the heart – the left and the right – and those patients require a two-chamber heart transplant to save their lives.
The two-chamber artificial heart transplant was performed by Prof. Jacob Lavee, Director of the Heart Transplantation Unit, and Dr. Yigal Kassif, and the anesthesia was provided by Dr. Sergey Preisman, Head of the Cardiac Surgery Anesthesia Unit.

Sheba Leverages ChatGPT
Accelerating Diagnostics: ChatGPT Results Aligned with Breast Cancer Board Recommendations
Recently, several distinguished Sheba clinicians were impressed by the tool’s capabilities. The group, which included Dr. Vera Sorin, Dr. Eyal Klang, Dr. Miri Sklair-Levy, Prof.…
Read More
Sheba and Vidac
Novel Drug Set to Improve CAR T-Cell Therapy Effectiveness
While many medical centers around the world depend on external labs to genetically engineer patient T-cells, a process that can take up to a few…
Read More
Sheba Named Global Oncology Leader
by Newsweek Magazine
Dedicated to providing those in need across the globe ‘Hope Without Boundaries,’ Sheba treats patients from more than 100 countries each year, employing the latest…
Read More